Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
13MAY

EMI reform quadruples the scaleup thresholds

3 min read
20:05UTC

Gross-assets limit jumps from £30m to £120m. Employee headroom doubles from 250 to 500. The share-option pool doubles to £6m. Most of this unlocks at Series B and C, not seed.

TechnologyDeveloping
Key takeaway

EMI's quadrupled limits help Series B+ retention while the sub-£2m tier hollows out at exactly the same speed.

Enterprise Management Incentives (EMI) reform took effect on 6 April 2026. The gross-assets test rose from £30m to £120m, the employee limit doubled from 250 to 500, and the share-option pool doubled from £3m to £6m. Lifetime company investment limits under EIS and VCT were also doubled to £24m. HM Treasury estimates the package unlocks roughly £100m a year across around 1,800 UK scaleups, equivalent to about 70,000 employees who can now receive tax-advantaged share options their employer's size previously excluded. 1

EMI lets qualifying small companies grant employees share options on which capital gains tax is charged at entrepreneurs' rates rather than as income, delivering materially higher net proceeds than cash bonuses for comparable employer cost. The old £30m gross-assets limit was the binding ceiling: scaleups breaching it had to drop EMI, typically at Series B or C, and replace it with non-tax-advantaged schemes. The new £120m ceiling lets a 400-person company at a £100m valuation keep offering tax-advantaged options through its growth phase; that was the policy intent.

The reform landed alongside the VCT relief cut . Read together, the two moves redistribute tax incentive away from pooled retail risk capital and toward direct scaleup employee compensation. That is coherent for companies of 250-500 staff raising above £5m; it does nothing for pre-revenue founders looking for a £500,000 cheque. The British Business Bank's direct mandate starts at £5m, and the UK grant-award picture continues to consolidate into fewer, bigger cheques.

CFOs at 250-500-headcount scaleups can reset option schemes at the next board meeting under the new £120m ceiling. Pre-Series-A founders see no change: the reform touches nothing in the capital environment below £5m. The policy machinery still has a visible gap between £250k and £2m, and none of the 6 April instruments reaches it.

Deep Analysis

In plain English

EMI stands for Enterprise Management Incentives. It is a government scheme that lets small British companies give their employees share options with a generous tax treatment, so that when the company succeeds, the employees share in the value they helped create. The problem was that the rules had a size limit; companies with assets over £30m could not use it. Since the late 1990s, inflation has meant that many growing technology companies hit that limit before they were anywhere near the public markets or an acquisition. The government has now raised the limit to £120m and doubled the total option pool, so more scaleup companies can keep using the scheme as they grow.

Deep Analysis
Root Causes

The 2022 gilt-market crisis pushed UK risk-free returns from near-zero to 4-5%, materially raising the opportunity cost for early-stage employees accepting below-market salaries in exchange for equity; the EMI reform responds to a talent-market shift rather than an innovation-policy shift, because the retention problem at Series A to C became acute specifically after 2022 when deferred compensation (options) started competing with observable, liquid alternatives.

The post-Brexit loss of the EU's pan-European patent court (before the UK's eventual accession to the Unified Patent Court in February 2023) created a period of IP uncertainty for scaleups filing multi-jurisdiction patents; that uncertainty increased the perceived risk of equity compensation for engineers, making higher option-pool values necessary to achieve the same retention effect.

What could happen next?
  • Consequence

    HMRC's estimated 14-month advance assurance backlog means the April 2026 reform will not be practically available to most scaleups until mid-2027; companies that need EMI options to close Series B hiring rounds before then will face a regulatory lag that partially negates the policy's intended effect.

  • Opportunity

    UK companies between £30m and £120m in gross assets that could not previously offer EMI options; estimated at 800-1,000 companies per Beauhurst's 2025 scaleup census; can now restructure their compensation mix, potentially reducing cash salary burn by 15-20% at the senior engineering level.

First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

GOV.UK (HM Treasury / DSIT)· 22 Apr 2026
Read original
Different Perspectives
Australian Department of Defence (AUKUS AI for Acoustics partner)
Australian Department of Defence (AUKUS AI for Acoustics partner)
Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.
DSIT / Liz Kendall, Secretary of State for Science
DSIT / Liz Kendall, Secretary of State for Science
DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.
Beauhurst / UK startup data analysts
Beauhurst / UK startup data analysts
Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.